Deerfield Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,600,000
| Closed | -$16.4M | – | 112 |
|
|
2023
Q2 | $16.4M | Hold |
1,600,000
| – | – | 0.35% | 54 |
|
|
2023
Q1 | $16.2M | Hold |
1,600,000
| – | – | 0.36% | 59 |
|
|
2022
Q4 | $16M | Hold |
1,600,000
| – | – | 0.33% | 65 |
|
|
2022
Q3 | $15.6M | Hold |
1,600,000
| – | – | 0.31% | 69 |
|
|
2022
Q2 | $15.5M | Hold |
1,600,000
| – | – | 0.32% | 68 |
|
|
2022
Q1 | $15.5M | Hold |
1,600,000
| – | – | 0.35% | 57 |
|
|
2021
Q4 | $15.7M | Hold |
1,600,000
| – | – | 0.33% | 67 |
|
|
2021
Q3 | $15.7M | Buy |
+1,600,000
| New | +$15.7M | 0.31% | 79 |
|